Insider Transactions (Form 4)
Last 7 days · 10,756 transactions ·
1,317 issuers
· Buys: 5,648
· Sells: 5,108
Only recent data is shown. Form 144 is not insider-trade execution data and is listed in SEC filings pages.
Filed = SEC submission date.
Page 30 of 108
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other
| Filed | Ticker | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | ACVA | Mehta Vikas | Chief Operating Officer | F | D (Sell) | 4,487.0 | 4.27 | 19,159.49 | 846,469.0 | View |
| Apr 03, 2026 | ACVA | Mehta Vikas | Chief Operating Officer | F | D (Sell) | 6,320.0 | 4.27 | 26,986.4 | 850,956.0 | View |
| Apr 03, 2026 | ACVA | Mehta Vikas | Chief Operating Officer | A | A (Buy) | 300,300.0 | 0.0 | 0.0 | 857,276.0 | View |
| Apr 03, 2026 | ADV | Gore Daniel | Chief Accounting Officer | F | D (Sell) | 1,785.0 | 19.19 | 34,254.15 | 6,665.0 | View |
| Apr 03, 2026 | ACVA | Fitzgerald Leanne | Chief Legal Officer | F | D (Sell) | 2,924.0 | 4.27 | 12,485.48 | 567,209.0 | View |
| Apr 03, 2026 | ACVA | Fitzgerald Leanne | Chief Legal Officer | F | D (Sell) | 3,553.0 | 4.27 | 15,171.31 | 570,133.0 | View |
| Apr 03, 2026 | ACVA | Fitzgerald Leanne | Chief Legal Officer | F | D (Sell) | 4,158.0 | 4.27 | 17,754.66 | 573,686.0 | View |
| Apr 03, 2026 | ACVA | Fitzgerald Leanne | Chief Legal Officer | F | D (Sell) | 5,821.0 | 4.27 | 24,855.67 | 577,844.0 | View |
| Apr 03, 2026 | ACVA | Fitzgerald Leanne | Chief Legal Officer | A | A (Buy) | 194,348.0 | 0.0 | 0.0 | 583,665.0 | View |
| Apr 03, 2026 | ACVA | Chamoun George | Chief Executive Officer | F | D (Sell) | 10,582.0 | 4.27 | 45,185.14 | 2,919,572.0 | View |
| Apr 03, 2026 | ACVA | Chamoun George | Chief Executive Officer | F | D (Sell) | 9,422.0 | 4.27 | 40,231.94 | 2,930,154.0 | View |
| Apr 03, 2026 | ACVA | Chamoun George | Chief Executive Officer | F | D (Sell) | 13,401.0 | 4.27 | 57,222.27 | 2,939,576.0 | View |
| Apr 03, 2026 | BIOA | RUBIN PAUL D | Chief Medical Officer | M | D (Sell) | 3,383.0 | 0.0 | 0.0 | 0.0 | View |
| Apr 03, 2026 | BIOA | RUBIN PAUL D | Chief Medical Officer | M | D (Sell) | 5,437.0 | 0.0 | 0.0 | 0.0 | View |
| Apr 03, 2026 | BIOA | RUBIN PAUL D | Chief Medical Officer | S | D (Sell) | 8,820.0 | 17.81 | 157,084.2 | 0.0 | View |
| Apr 03, 2026 | BIOA | RUBIN PAUL D | Chief Medical Officer | M | A (Buy) | 3,383.0 | 6.57 | 22,226.31 | 8,820.0 | View |
| Apr 03, 2026 | BIOA | RUBIN PAUL D | Chief Medical Officer | M | A (Buy) | 5,437.0 | 4.11 | 22,346.07 | 5,437.0 | View |
| Apr 03, 2026 | ACVA | Anderson Craig Eric | CCDSO | F | D (Sell) | 4,431.0 | 4.27 | 18,920.37 | 494,151.0 | View |
| Apr 03, 2026 | ACVA | Anderson Craig Eric | CCDSO | F | D (Sell) | 3,645.0 | 4.27 | 15,564.15 | 498,582.0 | View |
| Apr 03, 2026 | ACVA | Anderson Craig Eric | CCDSO | F | D (Sell) | 5,185.0 | 4.27 | 22,139.95 | 502,227.0 | View |
| Apr 03, 2026 | ACVA | Anderson Craig Eric | CCDSO | A | A (Buy) | 194,348.0 | 0.0 | 0.0 | 507,412.0 | View |
| Apr 03, 2026 | SGHT | Taylor Brenton | EVP, Operations & R&D | S | D (Sell) | 2,869.0 | 3.7 | 10,615.3 | 267,807.0 | View |
| Apr 03, 2026 | MET | Johnson Jeh C. | — | A | A (Buy) | 721.0 | 71.17 | 51,313.57 | 8,850.0 | View |
| Apr 03, 2026 | MET | WEINBERGER MARK A | — | A | A (Buy) | 721.0 | 0.0 | 0.0 | 18,801.0 | View |
| Apr 03, 2026 | MET | GUTIERREZ CARLOS M | — | A | A (Buy) | 721.0 | 0.0 | 0.0 | 25,745.0 | View |
| Apr 03, 2026 | SGHT | Badawi Paul | President and CEO | S | D (Sell) | 29,244.0 | 3.7 | 108,202.8 | 6,151,156.0 | View |
| Apr 03, 2026 | MET | Glaser Daniel S | — | A | A (Buy) | 721.0 | 71.17 | 51,313.57 | 2,101.0 | View |
| Apr 03, 2026 | WYNN | FERTITTA TILMAN J | — | S | D (Sell) | 200,000.0 | 3.8982 | 779,640.0 | 200,000.0 | View |
| Apr 03, 2026 | WYNN | FERTITTA TILMAN J | — | S | D (Sell) | 200,000.0 | 4.3713 | 874,260.0 | 200,000.0 | View |
| Apr 03, 2026 | MET | MCKENZIE DIANA | — | A | A (Buy) | 721.0 | 71.17 | 51,313.57 | 24,472.0 | View |
| Apr 03, 2026 | MET | Hay Laura J | — | A | A (Buy) | 721.0 | 71.17 | 51,313.57 | 5,692.0 | View |
| Apr 03, 2026 | ZBH | Noor Jehanzeb | See remarks below. | M | D (Sell) | 6,626.0 | 0.0 | 0.0 | 13,249.0 | View |
| Apr 03, 2026 | ZBH | Noor Jehanzeb | See remarks below. | F | D (Sell) | 1,677.0 | 90.67 | 152,053.59 | 5,151.0 | View |
| Apr 03, 2026 | ZBH | Noor Jehanzeb | See remarks below. | M | A (Buy) | 6,626.0 | 0.0 | 0.0 | 6,828.0 | View |
| Apr 03, 2026 | MET | Mumenthaler Christian Stephane | — | A | A (Buy) | 721.0 | 71.17 | 51,313.57 | 2,846.0 | View |
| Apr 03, 2026 | MET | MORRISON DENISE M | — | A | A (Buy) | 721.0 | 0.0 | 0.0 | 34,711.0 | View |
| Apr 03, 2026 | INSM | Adsett Roger | Chief Operating Officer | M | D (Sell) | 88,060.0 | 0.0 | 0.0 | 0.0 | View |
| Apr 03, 2026 | INSM | Adsett Roger | Chief Operating Officer | S | D (Sell) | 62,344.0 | 164.95 | 10,283,642.8 | 106,810.0 | View |
| Apr 03, 2026 | INSM | Adsett Roger | Chief Operating Officer | S | D (Sell) | 19,001.0 | 164.11 | 3,118,254.11 | 169,154.0 | View |
| Apr 03, 2026 | INSM | Adsett Roger | Chief Operating Officer | S | D (Sell) | 6,715.0 | 163.18 | 1,095,753.7 | 188,155.0 | View |
| Apr 03, 2026 | INSM | Adsett Roger | Chief Operating Officer | M | A (Buy) | 88,060.0 | 14.56 | 1,282,153.6 | 194,870.0 | View |
| Apr 03, 2026 | MET | HUBBARD ROBERT GLENN | — | A | A (Buy) | 1,248.0 | 71.17 | 88,820.16 | 105,878.0 | View |
| Apr 03, 2026 | MET | Kennard William E | — | A | A (Buy) | 721.0 | 71.17 | 51,313.57 | 46,501.0 | View |
| Apr 03, 2026 | MET | Harris Carla A | — | A | A (Buy) | 721.0 | 71.17 | 51,313.57 | 10,485.0 | View |
| Apr 03, 2026 | MET | Seitz Michelle | — | A | A (Buy) | 721.0 | 0.0 | 0.0 | 994.0 | View |
| Apr 03, 2026 | BSY | Moutte Julien | Chief Technology Officer | F | D (Sell) | 3,007.0 | 34.2 | 102,839.4 | 90,166.0 | View |
| Apr 03, 2026 | SBCF | FORLENZA JOSEPH M | EVP & CRO | F | D (Sell) | 310.0 | 30.58 | 9,479.8 | 2,792.0 | View |
| Apr 03, 2026 | SBCF | FORLENZA JOSEPH M | EVP & CRO | F | D (Sell) | 971.0 | 30.58 | 29,693.18 | 4,820.0 | View |
| Apr 03, 2026 | SBCF | FORLENZA JOSEPH M | EVP & CRO | F | D (Sell) | 290.0 | 30.58 | 8,868.2 | 0.0 | View |
| Apr 03, 2026 | SBCF | Kleffel Juliette | EVP, Chief Operating Officer | F | D (Sell) | 383.0 | 30.58 | 11,712.14 | 3,449.0 | View |
| Apr 03, 2026 | SBCF | Kleffel Juliette | EVP, Chief Operating Officer | F | D (Sell) | 1,286.0 | 30.58 | 39,325.88 | 6,385.0 | View |
| Apr 03, 2026 | SBCF | Kleffel Juliette | EVP, Chief Operating Officer | F | D (Sell) | 342.0 | 30.58 | 10,458.36 | 0.0 | View |
| Apr 03, 2026 | SBCF | Shaffer Charles M | Chairman, President & CEO | F | D (Sell) | 2,145.0 | 30.58 | 65,594.1 | 11,495.0 | View |
| Apr 03, 2026 | SBCF | Shaffer Charles M | Chairman, President & CEO | F | D (Sell) | 5,896.0 | 30.58 | 180,299.68 | 16,663.0 | View |
| Apr 03, 2026 | SBCF | Shaffer Charles M | Chairman, President & CEO | F | D (Sell) | 1,513.0 | 30.58 | 46,267.54 | 0.0 | View |
| Apr 03, 2026 | SBCF | DEXTER TRACEY | EVP & CFO | F | D (Sell) | 310.0 | 30.58 | 9,479.8 | 2,792.0 | View |
| Apr 03, 2026 | SBCF | DEXTER TRACEY | EVP & CFO | F | D (Sell) | 1,155.0 | 30.58 | 35,319.9 | 5,737.0 | View |
| Apr 03, 2026 | SBCF | DEXTER TRACEY | EVP & CFO | F | D (Sell) | 290.0 | 30.58 | 8,868.2 | 0.0 | View |
| Apr 03, 2026 | SBCF | Carroll Austen | EVP, Chief Lending Officer | F | D (Sell) | 383.0 | 30.58 | 11,712.14 | 3,449.0 | View |
| Apr 03, 2026 | SBCF | Carroll Austen | EVP, Chief Lending Officer | F | D (Sell) | 1,286.0 | 30.58 | 39,325.88 | 6,385.0 | View |
| Apr 03, 2026 | SBCF | Carroll Austen | EVP, Chief Lending Officer | F | D (Sell) | 342.0 | 30.58 | 10,458.36 | 0.0 | View |
| Apr 03, 2026 | SBCF | STALLINGS JAMES C III | EVP, Chief Credit Officer | F | D (Sell) | 255.0 | 30.58 | 7,797.9 | 2,299.0 | View |
| Apr 03, 2026 | SBCF | STALLINGS JAMES C III | EVP, Chief Credit Officer | F | D (Sell) | 734.0 | 30.58 | 22,445.72 | 3,647.0 | View |
| Apr 03, 2026 | SBCF | STALLINGS JAMES C III | EVP, Chief Credit Officer | F | D (Sell) | 239.0 | 30.58 | 7,308.62 | 0.0 | View |
| Apr 03, 2026 | SBCF | Arriola Eduardo J | — | F | D (Sell) | 73.0 | 30.58 | 2,232.34 | 283.0 | View |
| Apr 03, 2026 | QMCO | Craythorne Anthony | Chief Revenue Officer | A | A (Buy) | 148,500.0 | 0.0 | 0.0 | 148,500.0 | View |
| Apr 03, 2026 | QMCO | Nash Laura A. | Chief Accounting Officer | A | A (Buy) | 49,500.0 | 0.0 | 0.0 | 49,500.0 | View |
| Apr 03, 2026 | QMCO | Meyrath Hugues | President & CEO | A | A (Buy) | 850,000.0 | 0.0 | 0.0 | 850,000.0 | View |
| Apr 03, 2026 | IFF | Arora Yuvraj | President, Taste & CCO | M | D (Sell) | 4,305.0 | 72.57 | 312,413.85 | 29,534.0 | View |
| Apr 03, 2026 | IFF | Arora Yuvraj | President, Taste & CCO | A | A (Buy) | 13,780.0 | — | — | 33,839.0 | View |
| Apr 03, 2026 | IFF | Arora Yuvraj | President, Taste & CCO | F | D (Sell) | 2,203.0 | 72.57 | 159,871.71 | 15,539.0 | View |
| Apr 03, 2026 | IFF | Arora Yuvraj | President, Taste & CCO | M | A (Buy) | 4,305.0 | 0.0 | 0.0 | 17,742.0 | View |
| Apr 03, 2026 | IFF | Teles de Mendonca Ana Paula | President, Scent | M | D (Sell) | 2,583.0 | 72.57 | 187,448.31 | 21,451.0 | View |
| Apr 03, 2026 | IFF | Teles de Mendonca Ana Paula | President, Scent | A | A (Buy) | 12,402.0 | — | — | 24,034.0 | View |
| Apr 03, 2026 | IFF | Teles de Mendonca Ana Paula | President, Scent | F | D (Sell) | 932.0 | 72.57 | 67,635.24 | 4,410.0 | View |
| Apr 03, 2026 | IFF | Teles de Mendonca Ana Paula | President, Scent | M | A (Buy) | 2,583.0 | 0.0 | 0.0 | 5,342.0 | View |
| Apr 03, 2026 | IFF | DeVeau Michael | EVP, CFO | M | D (Sell) | 4,735.0 | 72.57 | 343,618.95 | 21,741.0 | View |
| Apr 03, 2026 | IFF | DeVeau Michael | EVP, CFO | A | A (Buy) | 16,536.0 | — | — | 26,476.0 | View |
| Apr 03, 2026 | IFF | DeVeau Michael | EVP, CFO | F | D (Sell) | 2,418.0 | 72.57 | 175,474.26 | 12,912.57 | View |
| Apr 03, 2026 | IFF | DeVeau Michael | EVP, CFO | M | A (Buy) | 4,735.0 | 0.0 | 0.0 | 15,330.57 | View |
| Apr 03, 2026 | IFF | Landsman Stephen N | EVP, General Counsel | M | D (Sell) | 3,228.0 | 72.57 | 234,255.96 | 21,616.0 | View |
| Apr 03, 2026 | IFF | Landsman Stephen N | EVP, General Counsel | A | A (Buy) | 15,158.0 | — | — | 24,844.0 | View |
| Apr 03, 2026 | IFF | Landsman Stephen N | EVP, General Counsel | F | D (Sell) | 1,164.0 | 72.57 | 84,471.48 | 17,164.0 | View |
| Apr 03, 2026 | IFF | Landsman Stephen N | EVP, General Counsel | M | A (Buy) | 3,228.0 | 0.0 | 0.0 | 18,328.0 | View |
| Apr 03, 2026 | IFF | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | D (Sell) | 2,030.0 | 72.57 | 147,317.1 | 23,152.0 | View |
| Apr 03, 2026 | IFF | Borg Deborah | EVP, Chief Ppl&Culture Officer | A | A (Buy) | 11,024.0 | — | — | 25,182.0 | View |
| Apr 03, 2026 | IFF | Borg Deborah | EVP, Chief Ppl&Culture Officer | F | D (Sell) | 819.0 | 72.57 | 59,434.83 | 35,449.0 | View |
| Apr 03, 2026 | IFF | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | A (Buy) | 2,030.0 | 0.0 | 0.0 | 36,268.0 | View |
| Apr 03, 2026 | IFF | Muller Andres Roberto | President, Food Ingredients | M | D (Sell) | 2,583.0 | 72.57 | 187,448.31 | 21,219.0 | View |
| Apr 03, 2026 | IFF | Muller Andres Roberto | President, Food Ingredients | A | A (Buy) | 12,402.0 | — | — | 23,802.0 | View |
| Apr 03, 2026 | IFF | Muller Andres Roberto | President, Food Ingredients | F | D (Sell) | 759.0 | 72.57 | 55,080.63 | 3,016.0 | View |
| Apr 03, 2026 | IFF | Muller Andres Roberto | President, Food Ingredients | M | A (Buy) | 2,583.0 | 0.0 | 0.0 | 3,775.0 | View |
| Apr 03, 2026 | IFF | Birenkrant Marc | Controller & CAO | M | D (Sell) | 473.0 | 72.57 | 34,325.61 | 2,007.0 | View |
| Apr 03, 2026 | IFF | Birenkrant Marc | Controller & CAO | A | A (Buy) | 2,480.0 | — | — | 2,480.0 | View |
| Apr 03, 2026 | IFF | Birenkrant Marc | Controller & CAO | F | D (Sell) | 171.0 | 72.57 | 12,409.47 | 3,945.15 | View |
| Apr 03, 2026 | IFF | Birenkrant Marc | Controller & CAO | M | A (Buy) | 473.0 | 0.0 | 0.0 | 4,116.15 | View |
| Apr 03, 2026 | IFF | Lourenco Leticia Goncalves | President, Health & Bioscience | M | D (Sell) | 4,305.0 | 72.57 | 312,413.85 | 28,417.0 | View |
| Apr 03, 2026 | IFF | Lourenco Leticia Goncalves | President, Health & Bioscience | M | D (Sell) | 3,013.0 | 72.57 | 218,653.41 | 32,722.0 | View |
| Apr 03, 2026 | IFF | Lourenco Leticia Goncalves | President, Health & Bioscience | A | A (Buy) | 13,780.0 | — | — | 35,735.0 | View |
| Apr 03, 2026 | IFF | Lourenco Leticia Goncalves | President, Health & Bioscience | F | D (Sell) | 1,908.0 | 72.57 | 138,463.56 | 4,075.0 | View |